Healt


 ImpediMed (ASX: IPD): This ASX biotech stock almost doubles in a day. Here's why

ImpediMed (ASX: IPD): This ASX biotech stock almost doubles in a day. Here's why

March 27, 2023 09:19 PM AEDT| By Neha Simpy

Highlights:,On Monday, ImpediMed Limited (ASX: IPD) announced an,updated NCCN Guidelines,®,to recommend frequent screening of lymphoedema with BIS.,The company has the only FDA-cleared BIS technology for the evaluation of lymphoedema.,In 2Q FY23, IPD...

 This ASX healthcare company receives takeover offer from Bain Capital; shares jump

This ASX healthcare company receives takeover offer from Bain Capital; shares jump

March 24, 2023 06:14 PM AEDT| By Neha Simpy

This ASX healthcare company receives takeover offer from Bain Capital; shares jump

 Healius Limited (ASX: HLS) jumps over 9% on takeover bid from ACL

Healius Limited (ASX: HLS) jumps over 9% on takeover bid from ACL

March 20, 2023 02:03 PM AEDT| By Neha Simpy

Healius Limited (ASX: HLS) jumps over 9% on takeover bid from ACL

 Neuren Pharmaceuticals’ (ASX:NEU) drug to treat Rett syndrome gets US FDA approval; shares up 20%

Neuren Pharmaceuticals’ (ASX:NEU) drug to treat Rett syndrome gets US FDA approval; shares up 20%

March 13, 2023 12:48 PM AEDT| By Priyabrata Prusty

Neuren Pharmaceuticals’ (ASX:NEU) drug to treat Rett syndrome gets US FDA approval; shares up 20%

 Why did this ASX biotech stock surge 29% today?

Why did this ASX biotech stock surge 29% today?

March 09, 2023 06:50 PM AEDT| By Neha Simpy

Prescient Therapeutics Limited (ASX: PTX) announced on Thursday that the FDA had granted orphan drug designation to PTX-100 for treating TCL

 Mesoblast (ASX: MSB) shares rally 14% as FDA accepts resubmission of BLA for new therapy

Mesoblast (ASX: MSB) shares rally 14% as FDA accepts resubmission of BLA for new therapy

March 08, 2023 06:12 PM AEDT| By Neha Simpy

Mesoblast Limited (ASX: MSB) share price skyrocketed after it updated that FDA had accepted its resubmission

 Why are Rhythm Biosciences (ASX: RHY) shares down nearly 50% today

Why are Rhythm Biosciences (ASX: RHY) shares down nearly 50% today

March 06, 2023 03:11 PM AEDT| By Neha Simpy

Rhythm Biosciences Limited (ASX: RHY) shares came under selling pressure and lost over half their market value on Monday

 Mayne Pharma Group Ltd (ASX: MYX) surges 28% in 5 days. Here’s why

Mayne Pharma Group Ltd (ASX: MYX) surges 28% in 5 days. Here’s why

March 02, 2023 11:24 AM AEDT| By Versha Jain

Mayne Pharma Group Limited (ASX: MYX) shares which closed with around 5% gain on 28 February, further jumped nearly 19% on Wednesday

 Ramsay Health Care (ASX: RHC) profit rises 22.3% in half year 2023; shares end 3% higher

Ramsay Health Care (ASX: RHC) profit rises 22.3% in half year 2023; shares end 3% higher

February 23, 2023 06:17 PM AEDT| By Neha Simpy

Ramsay Health Care Limited (ASX: RHC) reported 22.3% growth in its net profit and reported a 50 cents per share dividend (up 3.1% over pcp), sending its shares higher.

 Cochlear (ASX: COH) HY23 revenue rises 9%, guidance maintained

Cochlear (ASX: COH) HY23 revenue rises 9%, guidance maintained

February 15, 2023 06:01 PM AEDT| By Neha Simpy

The company reported a 9% jump in its revenue while maintaining net profit guidance for the current fiscal, leading to a sharp jump in its share price.

 Why is Mayne Pharma Group (ASX:MYX) in limelight today?

Why is Mayne Pharma Group (ASX:MYX) in limelight today?

January 18, 2023 01:37 PM AEDT| By Aditi Sarkar

• The stock price of Mayne Pharma Group (ASX:MYX) touched its 52-week high of AU$3.80 on mid-day trading hours today.

 Medibank (ASX:MPL) adds AU$207M to COVID-19 support fund

Medibank (ASX:MPL) adds AU$207M to COVID-19 support fund

December 23, 2022 12:08 PM AEDT| By Tamnna

Shares of Medibank were trading in the red territory, 0.503% down on the ASX as of 11:35 AM AEDT, 23 December. The value of each Medibank share was AU$2.965 at the same time.

 BWX (ASX:BWX) posts attributable loss of AU$337M

BWX (ASX:BWX) posts attributable loss of AU$337M

December 19, 2022 02:31 PM AEDT| By Sonal Goyal

BWX has posted a loss of AU$335 million during the financial year 2022.

 Know these ASX healthcare penny stocks

Know these ASX healthcare penny stocks

December 14, 2022 07:11 PM AEDT| By Aditi Sarkar

CU6, IMR, NSB and LCT are some of the ASX listed healthcare penny stocks that have registered decent price gains this month.

 CSL (ASX:CSL) appoints next CEO and managing director, shares on watch

CSL (ASX:CSL) appoints next CEO and managing director, shares on watch

December 13, 2022 01:19 PM AEDT| By Tamnna

On 13 December 2022, Australian biotechnology company CSL Limited (ASX:CSL) announced the appointment of Dr Paul McKenzie as its new chief executive officer (CEO) and managing director.

 What’s up with Nanosonics’ (ASX:NAN) shares today?

What’s up with Nanosonics’ (ASX:NAN) shares today?

December 13, 2022 11:08 AM AEDT| By Tamnna

Shares of Australia-based infection prevention company Nanosonics Limited (ASX:NAN) were spotted trading in the red territory on the ASX today (13 December 2022) despite there being no price-sensitive update from the company.

 How are Ansell’s (ASX:ANN) shares performing lately?

How are Ansell’s (ASX:ANN) shares performing lately?

December 12, 2022 11:17 AM AEDT| By Tamnna

One share of Ansell Limited was valued at AU$28.245 with a loss of 0.088% at 10:54 AM AEDT.

 Healius’ (ASX:HLS) shares on investors’ radar today, here’s why

Healius’ (ASX:HLS) shares on investors’ radar today, here’s why

December 09, 2022 12:27 PM AEDT| By Sonal Goyal

Share price of Healius has been in red territory after the company shared an update on CEO succession and sale of Montserrat Day Hospital.

 How artificial intelligence can revolutionise the course of precision medicine

How artificial intelligence can revolutionise the course of precision medicine

December 04, 2022 11:00 AM AEDT| By Aditi Sarkar

Complex algorithms, digital health apps, and omics-based testing are three categories of AI in precision medicine

 Fisher & Paykel Healthcare (ASX:FPH) first-half profit falls over 50%

Fisher & Paykel Healthcare (ASX:FPH) first-half profit falls over 50%

November 29, 2022 06:36 PM AEDT| By Tamnna

Following the 1H FY23 update, shares of Fisher & Paykel surged almost 10% higher on the ASX as its net profit retreated to pre-pandemic levels. One share of Fisher & Paykel was valued at AU$21.100 with a gain of 9.895% as of 3:52 PM AEDT on 29 Novemb...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.